About me
Ariel Katz is the CEO and Co-founder of H1, the connecting force for global HCP, clinical, scientific and research information. H1 works with the top Pharma and BioTech companies to deliver AI-powered insights to Medical Affairs and Clinical Operations to accelerate the discovery and engagement of industry experts, drive equitable research, access groundbreaking science, and get life saving treatments to patients faster. Ariel and team work directly with clients to help them apply healthcare data to solving vexing issues such as which treatments are the most promising, and which experts influence a particular market. Ariel started his first company in college, ResearchConnection, to help connect students with research opportunities. That company grew to over 40 universities and was eventually acquired by the Jefferson Accelerator Fund, Bill and Melinda Gates Foundation and the Ewing Kauffman Foundation.
